IP Library Patent Application 14669238
Patent Application
App. No. 14/669,238

SUBSTITUTED TETRACYCLINE COMPOUNDS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/669,238
Abstract

The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms.

Claims (19)

1 - 392 . (canceled)

393 . A substituted tetracycline compound of Formula (VIII):

wherein:

T is CR 7td ;

R 4 is alkylamino;

R 4′ is hydrogen;

R te is hydrogen;

R 7ta , R 7tb , and R 7tc are each independently hydrogen, halogen, hydroxyalkyl, hydroxyalkylaminocarbonyl, alkylaminoalkyloxy, aminocarbonyl, alkylaminoalkylaminocarbonyl, aminoalkylaminocarbon yl, methylpiperazinylcarbonyl, alkylaminocarbonyl, heteroarylalkylaminocarbonyl, alkoxycarbonylalkylaminocarbonyl, acylaminoalkylaminocarbonyl, alkoxyaminocarbonyl, alkoxyalkylaminocarbonyl or alkylaminoalkylcarbonylamino, or R 7tb and R 7tc are linked to form a ring; and

R 7td is hydroxyalkyl, alkylaminoalkylaminocarbonyl, dialkylaminoalkylaminocarbonyl, hydroxyalkylaminocarbonyl, aminoalkylaminocarbonyl, methylpiperazinylcarbonyl, heteroarylalkylaminocarbonyl, acylaminoalkylaminocarbonyl, or alkoxyalkylaminocarbonyl, or

a pharmaceutically acceptable salt thereof;

with the proviso that the compound of Formula (VIII) is not

or an enantiomer or diastereomer thereof.

394 . The compound of claim 393 , wherein R 7ta and R 7tc are each hydrogen.

395 . The compound of claim 393 , wherein one of R 7ta , R 7tb , and R 7tc is halogen.

396 . The compound of claim 395 , wherein R 7ta is halogen.

397 . The compound of claim 393 , wherein R 7tb and R 7tc are linked to form a ring.

398 . The compound of claim 393 , wherein R 7td is methylaminoalkylaminocarbonyl, dimethylaminoalkylaminocarbonyl, diethylaminoalkylaminocarbonyl, diisoproprylaminoalkylaminocarbonyl, pyrrolidinylalkylaminocarbonyl, piperidinylalkylaminocarbonyl, furanylalkylaminocarbonyl, ethoxycarbonylalkylaminocarbonyl, methoxyaminocarbonyl, or methoxyalkylaminocarbonyl.

399 . The compound of claim 393 , wherein the compound is represented by any one of the following structural formulas:

or a pharmaceutically acceptable salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2015
From: ABATO, PAUL; BOWSER, TODD
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 035412/0348 →